首页> 外文期刊>The Chinese-German Journal of Clinical Oncology >The Radiotherapy Effect of 512 Cases of Carcinoma of Cervix Uteri
【24h】

The Radiotherapy Effect of 512 Cases of Carcinoma of Cervix Uteri

机译:宫颈癌512例的放射治疗效果

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To report treatment results of 512 cases of carcinoma of uteri and investigate the way to improve treatment effects. Methods: The 5-year survival rate and the factors influencing the prognosis of 512 cases of uteri were analyzed retrospectively. Results: The 5-year survival rate after radiotherapy was as follows: stage Ⅰ: 100%; stage Ⅱ: 74.5%; stage Ⅲ: 56.5%; stage Ⅳ: 28.6%. Overall 5-year survival rate was 65.4%, which was almost the same as traditional intracavitary injection (65.7%). The 5-year survival rate in cervix lesions more than 4 cm and those less than or equal to 4 cm in stage Ⅱ was 63.9% and 79.3%, respectively, with statistically significant difference (P < 0.05). The 5-year survival rate of the patients with squamous carcinoma in stage Ⅱ was 77.0% and that with low differentiated squamous carcinoma was 64.0% respectively. Twenty-three (4.5%) out of 512 suffered from post-radiotherapy rectitis, 18 (3.5%) cystitis. Conclusion: the survival rate of the patients with cervix carcinoma subject to radiotherapy is stabilized to 65%. The diameter and pathological classes affect survival rate, respectively. Low radiotherapy dose decrease complications.
机译:目的:报告512例子宫癌的治疗结果,探讨提高治疗效果的途径。方法:回顾性分析512例子宫癌的5年生存率及影响预后的因素。结果:放疗后5年生存率如下:Ⅰ期:100%。 Ⅱ期:74.5%;第三阶段:56.5%;第四阶段:28.6%。 5年总生存率为65.4%,与传统腔内注射几乎相同(65.7%)。 Ⅱ期宫颈病变大于4 cm和小于等于4 cm的5年生存率分别为63.9%和79.3%,差异有统计学意义(P <0.05)。 Ⅱ期鳞癌患者的5年生存率分别为77.0%和低分化鳞癌患者的5年生存率分别为64.0%。在512名放射治疗后的直肠炎患者中,有23名(4.5%),18名(3.5%)患有膀胱炎。结论:宫颈癌放疗患者的生存率稳定在65%。直径和病理类别分别影响生存率。低放疗剂量可减少并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号